Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies

Z Xu, H Zhang, C Wu, Y Zheng, J Jiang - Frontiers in Cardiovascular …, 2022 - frontiersin.org
Background The cardiovascular protection effect of metformin on patients with type 2
diabetes mellitus (T2DM) remains inconclusive. This systemic review and meta-analysis …

Application of systemic inflammation indices and lipid metabolism-related factors in coronary artery disease

Z Zhao, H Lian, Y Liu, L Sun, Y Zhang - Coronary Artery Disease, 2023 - journals.lww.com
Objective We aimed to investigate the relationship between coronary artery disease (CAD)
and systemic inflammation indices and lipid metabolism-related factors and subsequently …

Preadmission metformin use increased the incidence of hyperlactatemia at admission and 30-day in-hospital mortality among T2D patients with heart disease at high …

L Zhang, X Zhao, Z Wang, H Deng, X Zhang… - International Journal of …, 2024 - Elsevier
Background Surprisingly, despite the high prevalence of metformin use in type 2 diabetes
(T2D) patients with heart disease, limited safety data is available regarding metformin use in …

Establishment of a Predictive Model for Poor Prognosis of Incomplete Revascularization in Patients with Coronary Heart Disease and Multivessel Disease

H Lian, Z Zhao, K Ma, Z Ding, L Sun… - Clinical and Applied …, 2022 - journals.sagepub.com
Objective To establish a predictive model for poor prognosis after incomplete
revascularization (ICR) in patients with multivessel coronary artery disease (MVD). Methods …

Glycaemic control and therapeutic inertia in patients with CAD and T2DM: a cross-sectional study in the Department of Cardiology

W Zhang, Q Peng, X Zhang, Q Xia - 2022 - researchsquare.com
Background The purpose of this study was to evaluate glycemic control in type 2 diabetes
mellitus (T2DM) patients with coronary artery disease in China, as well as to look into …